---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-001167"
form_type: "8-K"
ticker: "TGNT"
cik: "0000846377"
company_name: "Totaligent, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:56:37.218742+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Totaligent extends target closing date for Aetherium Medical acqui-hire to March 20, 2026

## Summary
- Extension Amendment moves target date for definitive agreements and closing from March 5 to March 20, 2026.
- Exclusivity period under the LOI remains in effect through April 5, 2026.
- Previously disclosed LOI on Feb 12, 2026, for acqui-hire of Aetherium team and IP in exchange for equity.
- Only the target timeline changed; all other LOI terms unchanged.

## SEC filing metadata
- accession: 0001477932-26-001167
- form_type: 8-K
- ticker: TGNT
- cik: 0000846377
- company_name: Totaligent, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/0001477932-26-001167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/totaligent_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-001167
- JSON: https://secwatch.observer/filing/0001477932-26-001167.json
- Plain text: https://secwatch.observer/filing/0001477932-26-001167.txt

## Key facts
- Material Agreements
  Totaligent, Inc. amended Extension Amendment with Aetherium Medical (effective 2026-03-04).
  - Action: amendment
  - Counterparty: Aetherium Medical
  - Effective: 2026-03-04
  source text: On March 4, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 11, 2026 (the “LOI”) with Aetherium Medical (“Aetherium”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/846377/000147793226001167/0001477932-26-001167-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.